rct
    2006
    High Quality

    Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope

    Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M

    Published in Circulation

    Key Findings

    Metoprolol did not reduce recurrence of syncope compared with placebo over one year.

    Conclusions

    Beta-blockers are not effective for preventing fainting in the general vasovagal population.

    Limitations

    Possible benefit in older subgroups not confirmed here.

    Related Health Concerns

    Fainting

    Study Details

    Year:2006
    Sample Size:208
    Duration:52 weeks
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.